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Abstract

While the impact of injection laryngoplasty on voice outcomes in unilateral vocal fold immobility has been well characterized, there is a relative paucity of literature investigating its influence on swallow function and outcomes. We performed a retrospective chart review of patients presenting to an academic cancer center between January 2014 and January 2016 to evaluate the clinical impact of percutaneous injection laryngoplasty on reduction of aspiration risk, patient perception of swallowing, and recommended safe diet in patients with vocal fold immobility after head and neck and thoracic surgery. A consecutive sample of patients diagnosed with unilateral vocal fold immobility with patient-or clinician-identified abnormal swallow function who underwent bedside or in-office
Introduction
Unilateral vocal fold immobility (UVFI) is a known complication of head and neck and thoracic surgery, resulting from manipulation or transection of the recurrent laryngeal nerve (RLN). 1 As a result, the ipsilateral true vocal fold may assume a paramedian or lateral position, putting the patient at risk for dysphonia, poor cough reflex, exercise intolerance, dysphagia, and aspiration. 1 Videofluoroscopic swallowing studies have demonstrated aspiration rates of 23 to 53% in patients with UVFI, with loss of laryngopharyngeal motor and sensory function thought to play predominant etiologic roles. 1 Several techniques have been developed to address the glottic insufficiency caused by UVFI, including voice therapy, medialization thyroplasty, arytenoid adduction, and injection laryngoplasty. 1 As techniques have become more refined, data have become available demonstrating the safety and efficacy of injection laryngoplasty. 2 This intervention not only bypasses a costly trip to the operating room, but it also avoids the danger of putting patients with myriad medical comorbidities under general anesthesia. 3 Many studies have described the utility of injection laryngoplasty in improving voice quality in patients with UVFI, but studies solely assessing its efficacy in improving swallow outcomes have been limited.
Many of the patients in the authors' clinical practice develop UVFI because of thoracic and head and neck cancers and/or related surgical procedures; these patients are often chronic smokers with compromised pulmonary status related to their disease or treatment, making the sequelae of aspiration potentially even more detrimental in this patient population. The aim of this study, therefore, is to evaluate the impact of injection laryngoplasty on patient swallow outcomes, including diet advancement, in patients with swallowing complaints after onset of UVFI; those requiring behavioral modifications during swallow; or those designated nil per os (NPO) because of the presence of an unsafe swallow.
We hypothesize that an improvement in subjective and objective measures of swallow function will be Improved swallow outcomes after InjectIon laryngoplasty In unIlateral vocal fold ImmobIlIty demonstrated in patients suffering from UVFI after medialization of the immobile true vocal fold via injection laryngoplasty.
Case report Approval for this study was granted by the Fox Chase Cancer Center (FCCC) Institutional Review Board.
A retrospective chart review was completed on all patients diagnosed with new-onset UVFI at FCCC between January 2014 and January 2016. Diagnosis was made by an otolaryngologist via flexible fiberoptic laryngoscopy, typically within 1 week of surgical insult for inpatients, or within 1 month of voice change in outpatients, who were in the interim diagnosed with locoregionally aggressive or metastatic disease.
To be included in the study, patients had to meet the following criteria: presence of UVFI associated with patient-or clinician-identified abnormal swallow function, performance of successful injection laryngoplasty, and presence of pre-and postinjection fiberoptic endoscopic evaluation of swallowing (FEES) results and Eating Assessment Tool-10 (EAT-10) scores. Patients who were lost to follow-up, who had incomplete preand postinjection survey results, and those who had received injections for voice rehabilitation only were excluded from the study.
Injection laryngoplasty was performed at bedside or in the office for inpatients and outpatients, respectively, by the same attending otolaryngologist using a percutaneous transcartilaginous (thyroid cartilage) or transmembranous (cricothyroid membrane) technique with carboxymethylcellulose (Prolaryn Gel; Merz; Raleigh, N.C.).
Pre-and postinjection EAT-10 scores were assigned for all patients included in the study, as validated by Belafsky et al for patients with swallow disorders (table  1) . 4 Preinjection EAT-10 scores were collected immediately before injection. Postinjection EAT-10 scores were collected during the 1-month postinjection follow-up outpatient visits.
Upon receiving a diagnosis of UVFI, patients underwent FEES by a speech and language pathologist (SLP) to assess swallow dynamics, to interrogate laryngopharyngeal sensation, to investigate for the presence of aspiration or penetration, and to determine a safe diet. Functional Oral Intake Scale (FOIS) score was assigned, as described by Crary et al, based on FEES findings. 5 Injection laryngoplasty was performed 1 to 7 days after the initial FEES and, immediately after injection, a repeat FEES was performed to assess for improvement in swallow and eligibility for safe diet advancement.
Statistical analysis was completed using the Statistical Package for the Social Sciences (ver. 24). Pre-and postinjection FOIS and EAT-10 data were compared with a Wilcoxon signed rank test, which is a nonparametric hypothesis test used to compare matched samples.
Results
The charts of 48 patients diagnosed with UVFI within the study period were identified, 21 of whom met the inclusion criteria. Patients excluded had incomplete pre-and postinjection diet and swallow data, were lost to follow-up, or declined intervention with injection laryngoplasty. Patient demographic data, etiology of UVFI, indication for injection laryngo- 4 and used to assess subjective dysphagia complaints.
Zuniga, EbErsolE, Jamal plasty, and injection material used were similar in all included patients (table 2) . The mean patient age at the time of diagnosis of UVFI was 65 years (±11 years). Eleven men and 10 women comprised the study cohort. Ninety percent of patients suffered left-sided UVFI. Table 2 outlines the distribution of etiologies for UVFI, the majority being the result of iatrogenic surgical injury or malignant invasion by local or metastatic malignancy.
The indication for injection for all patients in the study was dysphagia with or without dysphonia. FEES was performed by an experienced SLP to determine aspiration risk and safe oral diet based on FOIS scoring. One of 21 patients was made strictly NPO before injection laryngoplasty (FOIS score 1); the remainder tolerated a regular diet or were required to adhere to behavioral modifications with oral intake (FOIS scores 5 to 7) (tables 3 and 4).
All 8 patients who initially required restricted diets (FOIS score 5) were able to advance to a regular diet without the use of behavioral modifications (FOIS score 7). The 1 patient who was NPO before injection (FOIS score 1) was able to safely tolerate a PO diet with behavioral modification after injection laryngoplasty (FOIS 5) (table 4). The remaining 12 patients did not require dietary modification preinjection, but they did experience subjective dysphagia, as demonstrated by their abnormal EAT-10 scores.
A statistically significant difference was observed between patients' pre-and postinjection FOIS and EAT-10 scores, with improvement noted after injection (p = 0.004 and p = 0.04, respectively) (tables 5 and 6). 
Discussion
Several studies have demonstrated that injection laryngoplasty improves subjective and objective measures of voice, including scores on the voice-related quality of life (VRQOL); the Grade of Dysphonia, Roughness, Breathiness, Asthenia, Strain (GRBAS) scale; and maximum phonation time (MPT). 6 Although the benefits of injection laryngoplasty regarding improvement of vocal quality have been well studied, the specific contribution that medialization procedures may have on improvement of swallow function has been less thoroughly evaluated. The aim of this study, therefore, was to evaluate objective and subjective measures of swallow before and after intervention with injection laryngoplasty in patients newly diagnosed with UVFI to determine potential benefits to swallow function.
Although the incidence of penetration and aspiration events in patients with UVFI varies considerably in the literature, the general consensus is that these patients are at heightened risk for dysphagia and aspiration. 7 Previous investigations have reported that approximately 60% of patients with UVFI complain of dysphagia, which may represent a wide range of swallow impairment, from no objective impairment to gross aspiration. 7 The most potentially devastating consequence of UVFI is aspiration-related pulmonary sequelae; thus, prompt identification and evaluation is prudent.
Many of the patients in our cohort developed UVFI as a result of a thoracic surgical procedure. Patients who undergo thoracic surgery often possess compromised pulmonary status and decreased pulmonary reserve because of disease, treatment, or other medical comorbidities, making the sequelae of aspiration potentially more detrimental in this patient population,
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Zuniga, EbErsolE, Jamal as well as in chronic smokers with head and neck cancer. The need for alternate enteral access in those with an unsafe swallow also produces a detriment to patient quality of life and levies a psychological burden on patients already suffering from other serious disease processes. 8 FEES was the investigative modality of choice to interrogate swallow function in our patient population. Videofluoroscopic examination of swallow (VFS) has long been considered the "gold standard" in assessment of pharyngeal swallow function; however, several studies have demonstrated numerous advantages afforded by FEES over VFS. [9] [10] [11] Specifically, Langmore et al showed an acceptable level of sensitivity, specificity, positive predictive value, and negative predictive value in identifying aspiration, penetration, bolus residue, and spillage during FEES compared with the results of the VFS study done on the same individuals. 9 The increasingly ubiquitous availability of this technology in clinical practice combined with the expanding cohort of clinicians becoming facile with both the administration and interpretation of this modality makes it a reliable and generalizable diagnostic technique.
The FOIS allows quantitative description of diet advancement after injection laryngoplasty. All patients in our study who were initially prescribed a restricted diet due to their UVFI were able to have their diet advanced immediately after injection laryngoplasty. This improvement in FOIS scores from pre-to postinjection was statistically significant (table 5) , supporting an improvement in swallow safety after injection laryngoplasty. Graboyes et al demonstrated similar findings in their series of 20 patients in which 90% of their cohort were recommended for strict NPO before injection. Of these, 94% were allowed an oral diet and 67% tolerated a regular diet after injection. 12 Given the relatively high rate of subjective reports of dysphagia in UVFI, the EAT-10 instrument was used to measure changes in patient perception of swallow. EAT-10 was validated by Belafsky et al in a group of patients with known reflux, voice disorders, oropharyngeal dysphagia, head and neck cancer, or esophageal dysphagia, with dysphagia etiologies ranging from neurologic disease to esophageal webs and stricture. 4 In the current patient population, a statistically significant improvement was demonstrated when comparing pre-and postinjection EAT-10 scores (table  6) , supporting improvement in patient perception of swallow, even in the absence of the need for dietary modification. The degree of improvement represents a meaningful benefit, as dysphagia is a well-documented detriment to quality of life. 13 Cates et al demonstrated similar findings to ours in their evaluation of 44 patients who underwent either injection laryngoplasty or medialization thyroplasty for UVFI, demonstrating a durable and statistically significant improvement in EAT-10 after the medializa- Improved swallow outcomes after InjectIon laryngoplasty In unIlateral vocal fold ImmobIlIty tion procedure. 13 In contrast to our study, however, the Cates study does not report objective measures of diet advancement or behavioral diet modifications before or after surgical intervention.
Although intact motor and sensory function is clearly necessary to mediate the complex sequence of events during swallow, the individual contribution and importance of these unique motor and sensory mechanisms is difficult to elucidate. Improvement in glottic valving likely plays a role in improving intrabolus pressure generation, and these mechanisms in combination may reduce aspiration while increasing bolus clearance. 14 Bhattacharyya et al evaluated swallow impairment in patients with UVFI via VFS and noted laryngeal penetration during and after swallow due to bolus residue in the pharynx. 7 They postulated that an incompetent glottic valve may impair the necessary negative hypopharyngeal pump pressure needed to propel the bolus through the pharynx, thus predisposing the patient to aspiration. 7 However, although glottal competence is paramount to swallow safety during deglutition, intact sensory function is essential for the coordination of events during the swallow, as well as to elicit reflex clearance of materials from the hypopharynx, larynx, and trachea. 1 Further, other biomechanical factors, including pharyngeal strength and upper esophageal sphincter opening, have been demonstrated to significantly influence swallow efficiency.
Nayak et al investigated patterns of failure after medialization procedures for UVFI, suggesting that pharyngeal transport defects and bolus residue in persistent penetration or aspiration play leading roles in failure, despite glottic competence. 15 Domer et al demonstrated significantly prolonged pharyngeal transit time and decreased pharyngeal strength in patients with UVFI, thus supporting the notion that mechanical factors other than glottal competence contribute to the increased incidence of penetration and aspiration in this patient population. 16 Because swallowing is a complex, multistep process that requires various motor and sensory inputs, swallow outcomes after medialization procedures in patients with UVFI have yielded diverse results. The findings of our study suggest a greater derived benefit than in several prior studies. The greater benefit realized in our study may be explained by isolated unilateral RLN injury as the etiology of UVFI in patients included in our cohort, in contrast to similar studies, which have included patients with UVFI resulting from radiation, cerebrovascular accident, skull base pathology, or central nervous system dysfunction. 2, 7, [17] [18] [19] Patients suffering from multiple cranial neuropathies or central nervous system dysfunction may receive less benefit from medialization procedures given multiple levels of laryngeal dysfunction. 16 Despite the etiologic homogeneity of our study population, our findings remain pertinent as surgical trauma to the RLN is the most commonly cited etiology of UVFI. 16 Interestingly, 57% of patients in our study did not have aspiration associated with their dysphagia. Why some patients experience aspiration with UVFI while others do not also remains poorly understood. The authors suspect that baseline swallowing efficiency, degree of glottic closure post-UVFI development, impaired laryngeal sensation, and pulmonary status likely play a role. Further research is required to better understand the risk factors for developing aspiration after UVFI.
Our study has several methodologic limitations. The limitations inherent to any retrospective study are present in this study, including incomplete follow-up data in many patients. To compensate, we designed our study with rigid inclusion criteria to optimize the accuracy and integrity of the presented data. As a result, however, of the 48 patients diagnosed with UVFI during the study period, only 21 patients had complete data for objective and subjective swallow outcomes for pre-and postinjection laryngoplasty.
Unfortunately, as all patients included had head and neck or thoracic cancer, a considerable number of patients were unable to complete adequate follow-up because of disease progression, disability, or death. As a result, small sample size was another weakness of our study. Our study also did not feature a control group to which we might have compared swallow outcomes. Finally, a selection bias may also be present in that patients included suffered from significant swallow detriment due to their UVFI and were thus more likely to desire treatment. retrospective nature, which limited our ability to acquire information on our patients' phonatory behavior, voice quality, and endoscopic laryngeal findings. Another is the absence of indirect laryngeal examination, which would have been of value in excluding other possible laryngeal pathologies such as vocal fold paresis and in allowing us to draw other conclusions of possible clinical significance.
In conclusion, ankylosis and narrowing of the cricoarytenoid joint are commonly observed with aging. CT can be used to measure these changes and assist in the workup of elderly patients with dysphonia and abnormal vocal fold movement disorders.
